Loss-of-function mutation in


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
26 Nov 2021
Historique:
entrez: 26 11 2021
pubmed: 27 11 2021
medline: 8 3 2022
Statut: ppublish

Résumé

The Ikaros family transcription factors regulate lymphocyte development. Loss-of-function variants in

Identifiants

pubmed: 34826260
doi: 10.1126/sciimmunol.abe3454
doi:

Substances chimiques

IKZF2 protein, human 0
Ikaros Transcription Factor 148971-36-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabe3454

Auteurs

Iivo Hetemäki (I)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Meri Kaustio (M)

Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.

Matias Kinnunen (M)

Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

Nelli Heikkilä (N)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Salla Keskitalo (S)

Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

Kirsten Nowlan (K)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Simo Miettinen (S)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Joona Sarkkinen (J)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Virpi Glumoff (V)

Research Unit of Biomedicine, University of Oulu, Oulu, Finland.

Noora Andersson (N)

Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Kaisa Kettunen (K)

Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Department of Clinical Genetics and HUSLAB Laboratory of Genetics, Helsinki University Hospital, Helsinki, Finland.

Reetta Vanhanen (R)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Katariina Nurmi (K)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Kari K Eklund (KK)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Orton Orthopaedic Hospital of the Orton Foundation, Helsinki, Finland.

Johannes Dunkel (J)

Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Mikko I Mäyränpää (MI)

Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Heinrich Schlums (H)

Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

T Petteri Arstila (TP)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Kai Kisand (K)

Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.

Yenan T Bryceson (YT)

Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Broegelmann Research Laboratory, Department of Clinical Sciences, University of Bergen, Bergen, Norway.

Pärt Peterson (P)

Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.

Ulla Otava (U)

Infectious Disease Unit, Department of Internal Medicine, Tampere University Hospital, Tampere, Finland.

Jaana Syrjänen (J)

Infectious Disease Unit, Department of Internal Medicine, Tampere University Hospital, Tampere, Finland.

Janna Saarela (J)

Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
Department of Clinical Genetics and HUSLAB Laboratory of Genetics, Helsinki University Hospital, Helsinki, Finland.
Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway.
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

Markku Varjosalo (M)

Institute of Biotechnology, HiLIFE Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

Eliisa Kekäläinen (E)

Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH